Dynavax Technologies Corporation to Present at the JMP Securities Healthcare Conference

Published: Jul 02, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BERKELEY, CA--(Marketwired - July 02, 2013) - Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that it will present at the JMP Securities Healthcare Conference in New York on Wednesday, July 10 at 9:00 a.m. EDT (6:00 a.m. PDT).

Michael Ostrach, Chief Business Officer of Dynavax, will provide a corporate overview presentation. To access the slide presentation, live webcast, and subsequent archived recording, please visit Dynavax's website at http://investors.dynavax.com/newsevents.cfm.

About Dynavax

Dynavax, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases. Dynavax's lead product candidate is HEPLISAV™, a Phase 3 investigational adult hepatitis B vaccine. For more information visit www.dynavax.com.

Michael Ostrach
Vice President and Chief Business Officer
Email Contact

Help employers find you! Check out all the jobs and post your resume.

Back to news